Aegis Awarded Patent for Fast Acting Nasal Spray Opioid Blockers and Pain Medications SAN DIEGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 9,895,444 providing non-invasive metered nasal spray delivery of multiple...

Aegis Announces Breakthrough in Non-Invasive, Rapid Onset, Acute Pain Control SAN DIEGO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Aegis Therapeutics has developed a metered nasal spray formulation of hydromorphone having rapid onset of drug action (approximately 1 min. with a Tmax...

U.S. ‘Smart Pill’ Industry Could Double, Top $1.2 Billion By 2021 Wellesley, Mass., May 29, 2017 (GLOBE NEWSWIRE) -- A new global market study by BCC Research indicates a growth trajectory above 20%-per-year in the ‘Smart Pill’ segment of the medical and...